Newcastle University, in collaboration with Genesis Therapeutics, offers a studentship focusing on machine learning to enhance drug discovery processes. The successful candidate will model interactions between drugs and proteins, leveraging quantum mechanical data.
This 4-year award provides full home fees coverage and a living allowance, starting on 16th September 2024. Candidates must meet specific eligibility criteria, including residency requirements. Interested applicants should contact Dr. Daniel Cole at daniel.cole@ncl.ac.uk by 21st May 2024.
#J-18808-Ljbffr…
